SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-20-005914
Filing Date
2020-04-30
Accepted
2020-04-30 08:48:52
Documents
70
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q lnth10q-033120.htm   iXBRL 10-Q 1163161
2 EXHIBIT 31.1 lnth10q-033120ex311.htm EX-31.1 14950
3 EXHIBIT 31.2 lnth10q-033120ex312.htm EX-31.2 15043
4 EXHIBIT 32.1 lnth10q-033120ex321.htm EX-32.1 13797
  Complete submission text file 0001628280-20-005914.txt   4809727

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lnth-20200331.xsd EX-101.SCH 33790
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lnth-20200331_cal.xml EX-101.CAL 72361
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lnth-20200331_def.xml EX-101.DEF 99438
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lnth-20200331_lab.xml EX-101.LAB 433105
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lnth-20200331_pre.xml EX-101.PRE 242820
26 EXTRACTED XBRL INSTANCE DOCUMENT lnth10q-033120_htm.xml XML 735364
Mailing Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Business Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862 978 671-8001
Lantheus Holdings, Inc. (Filer) CIK: 0001521036 (see all company filings)

IRS No.: 352318913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36569 | Film No.: 20833399
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences